Sökning: onr:"swepub:oai:DiVA.org:liu-195776" > New-onset atrial fi...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 04634naa a2200445 4500 | |
001 | oai:DiVA.org:liu-195776 | |
003 | SwePub | |
008 | 230627s2023 | |||||||||||000 ||eng| | |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-1957762 URI |
024 | 7 | a https://doi.org/10.1111/aas.142622 DOI |
040 | a (SwePub)liu | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Andreasen, Anne Sofieu Copenhagen Univ Hosp Herlev, Denmark4 aut |
245 | 1 0 | a New-onset atrial fibrillation in critically ill adult patients-an SSAI clinical practice guideline |
264 | 1 | b WILEY,c 2023 |
338 | a electronic2 rdacarrier | |
500 | a Funding Agencies|Scandinavian Society of Anaesthesiology and Intensive Care Medicine (SSAI) | |
520 | a Background: Acute or new-onset atrial fibrillation (NOAF) is the most common cardiac arrhythmia in critically ill adult patients, and observational data suggests that NOAF is associated to adverse outcomes. Methods: We prepared this guideline according to the Grading of Recommendations Assessment, Development and Evaluation methodology. We posed the following clinical questions: (1) what is the better first-line pharmacological agent for the treatment of NOAF in critically ill adult patients?, (2) should we use direct current (DC) cardioversion in critically ill adult patients with NOAF and hemodynamic instability caused by atrial fibrillation?, (3) should we use anticoagulant therapy in critically ill adult patients with NOAF?, and (4) should critically ill adult patients with NOAF receive follow-up after discharge from hospital? We assessed patient-important outcomes, including mortality, thromboembolic events, and adverse events. Patients and relatives were part of the guideline panel. Results: The quantity and quality of evidence on the management of NOAF in critically ill adults was very limited, and we did not identify any relevant direct or indirect evidence from randomized clinical trials for the prespecified PICO questions. We were able to propose one weak recommendation against routine use of therapeutic dose anticoagulant therapy, and one best practice statement for routine follow-up by a cardiologist after hospital discharge. We were not able to propose any recommendations on the better first-line pharmacological agent or whether to use DC cardioversion in critically ill patients with hemodynamic instability induced by NOAF. An electronic version of this guideline in layered and interactive format is available in MAGIC: https://app.magicapp.org/#/guideline/7197. Conclusions: The body of evidence on the management of NOAF in critically ill adults is very limited and not informed by direct evidence from randomized clinical trials. Practice variation appears considerable. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Kardiologi0 (SwePub)302062 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Cardiac and Cardiovascular Systems0 (SwePub)302062 hsv//eng |
653 | a clinical practice guideline; MAGIC; new-onset atrial fibrillation | |
700 | 1 | a Wetterslev, Miku Copenhagen Univ Hosp Rigshosp, Denmark4 aut |
700 | 1 | a Sigurdsson, Martin Ingiu Landspitali Natl Univ Hosp Iceland, Iceland; Univ Iceland, Iceland4 aut |
700 | 1 | a Bove, Jeppeu Odense Univ Hosp, Denmark4 aut |
700 | 1 | a Kjaergaard, Jesperu Copenhagen Univ Hosp Rigshosp, Denmark4 aut |
700 | 1 | a Aslam, Tayyba Nazu Oslo Univ Hosp, Norway; Univ Oslo, Norway4 aut |
700 | 1 | a Jarvela, Katiu Tampere Univ Hosp, Finland4 aut |
700 | 1 | a Poulsen, Metteu Aarhus Univ Hosp, Denmark4 aut |
700 | 1 | a de Geer, Linau Linköpings universitet,Avdelningen för klinisk kemi och farmakologi,Medicinska fakulteten,Region Östergötland, ANOPIVA US4 aut0 (Swepub:liu)linde65 |
700 | 1 | a Agarwal, Arnavu McMaster Univ, Canada; McMaster Univ, Canada; MAGIC Evidence Ecosyst Fdn, Norway4 aut |
700 | 1 | a Kjaer, Maj-Brit Norregaardu Copenhagen Univ Hosp Rigshosp, Denmark4 aut |
700 | 1 | a Moller, Morten Hylanderu Copenhagen Univ Hosp Rigshosp, Denmark; Univ Copenhagen, Denmark4 aut |
710 | 2 | a Copenhagen Univ Hosp Herlev, Denmarkb Copenhagen Univ Hosp Rigshosp, Denmark4 org |
773 | 0 | t Acta Anaesthesiologica Scandinavicad : WILEYg 67:8, s. 1110-1117q 67:8<1110-1117x 0001-5172x 1399-6576 |
856 | 4 | u https://liu.diva-portal.org/smash/get/diva2:1775685/FULLTEXT01.pdfx primaryx Raw objecty fulltext:print |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-195776 |
856 | 4 8 | u https://doi.org/10.1111/aas.14262 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
Kopiera och spara länken för att återkomma till aktuell vy